This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2016 Jul 1;176(7):1005-6.

doi: 10.1001/jamainternmed.2016.1979.

Nonfasting for Routine Lipid Testing: From Evidence to Action

Samia Mora¹

Affiliations

Affiliation

¹ Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts2Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical Sc.

PMID: 27119719
DOI: 10.1001/jamainternmed.2016.1979

Review

Nonfasting for Routine Lipid Testing: From Evidence to Action

Samia Mora. JAMA Intern Med. 2016.

. 2016 Jul 1;176(7):1005-6.

doi: 10.1001/jamainternmed.2016.1979.

Author

Samia Mora¹

Affiliation

¹ Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts2Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical Sc.

PMID: 27119719
DOI: 10.1001/jamainternmed.2016.1979

No abstract available

PubMed Disclaimer

Similar articles

Nonfasting lipid testing: the new standard for cardiovascular risk assessment.
Darras P, Mattman A, Francis GA. Darras P, et al. CMAJ. 2018 Nov 12;190(45):E1317-E1318. doi: 10.1503/cmaj.180804. CMAJ. 2018. PMID: 30420386 Free PMC article. No abstract available.
Nonfasting versus fasting lipid profile for cardiovascular risk prediction.
Langsted A, Nordestgaard BG. Langsted A, et al. Pathology. 2019 Feb;51(2):131-141. doi: 10.1016/j.pathol.2018.09.062. Epub 2018 Dec 3. Pathology. 2019. PMID: 30522787 Review.
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL. Brunzell JD, et al. J Am Coll Cardiol. 2008 Apr 15;51(15):1512-24. doi: 10.1016/j.jacc.2008.02.034. J Am Coll Cardiol. 2008. PMID: 18402913 Review. No abstract available.
Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.
Stalenhoef AF, de Graaf J. Stalenhoef AF, et al. Curr Opin Lipidol. 2008 Aug;19(4):355-61. doi: 10.1097/MOL.0b013e328304b63c. Curr Opin Lipidol. 2008. PMID: 18607182 Review.
Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T, Obata JE, Hirano M, Kitta Y, Fujioka D, Saito Y, Kawabata K, Watanabe K, Watanabe Y, Mishina H, Kugiyama K. Nakamura T, et al. Atherosclerosis. 2011 Sep;218(1):163-7. doi: 10.1016/j.atherosclerosis.2011.04.040. Epub 2011 May 6. Atherosclerosis. 2011. PMID: 21605862

See all similar articles

Cited by

Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease.
Zhang J, Tang Z, Jiang J, Huang S, Zeng H, Gu J, Wang C, Zhang H. Zhang J, et al. Rev Cardiovasc Med. 2023 Nov 9;24(11):314. doi: 10.31083/j.rcm2411314. eCollection 2023 Nov. Rev Cardiovasc Med. 2023. PMID: 39076452 Free PMC article.
Unraveling the controversy between fasting and nonfasting lipid testing in a normal population: a systematic review and meta-analysis of 244,665 participants.
Zaid AB, Awad SM, El-Abd MG, Saied SA, Almahdy SK, Saied AA, Elmalawany AM, AboShabaan HS, Saleh HS. Zaid AB, et al. Lipids Health Dis. 2024 Jun 27;23(1):199. doi: 10.1186/s12944-024-02169-y. Lipids Health Dis. 2024. PMID: 38937752 Free PMC article. Review.
A higher non-HDL-C/HDL-C ratio was associated with an increased risk of progression of nonculprit coronary lesion in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Liu J, Zhao L, Zhang Y, Wang L, Feng Q, Cui J, Zhang W, Zheng J, Wang D, Zhao F, He J, Chen Y. Liu J, et al. Clin Cardiol. 2024 Feb;47(2):e24243. doi: 10.1002/clc.24243. Clin Cardiol. 2024. PMID: 38402557 Free PMC article.
Plasma metabolomics supports non-fasted sampling for metabolic profiling across a spectrum of glucose tolerance in the Nile rat model for type 2 diabetes.
Anderson BJ, Curtis AM, Jen A, Thomson JA, Clegg DO, Jiang P, Coon JJ, Overmyer KA, Toh H. Anderson BJ, et al. Lab Anim (NY). 2023 Nov;52(11):269-277. doi: 10.1038/s41684-023-01268-0. Epub 2023 Oct 19. Lab Anim (NY). 2023. PMID: 37857753 Free PMC article.
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk.
Baratta F, Cocomello N, Coronati M, Ferro D, Pastori D, Angelico F, Ben MD. Baratta F, et al. Int J Mol Sci. 2023 Feb 21;24(5):4268. doi: 10.3390/ijms24054268. Int J Mol Sci. 2023. PMID: 36901696 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information